Versagenics Inc is categorized under Commercial Medical Research in Cary, NC and active since 2003.
Versagenics Inc was established in 2003, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 9999900 by the NAICS.
If you are seeking more information, feel free to contact Donald Fortin, President at the company’s single location by writing to 14001 Weston Parkway # 101, Cary, North Carolina NC 27513 or by phoning (919) 481-0990. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Versagenics Inc |
| Contact Person: | Donald Fortin, President |
| Address: | 14001 Weston Parkway # 101, Cary, North Carolina 27513 |
| Phone Number: | (919) 481-0990 |
| Website Address: | versagenics.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 9999900 |
| Share This Business: |
Versagenics Inc was started in 2003 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 9999900. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Donald Fortin, President for inquiries that concern Versagenics Inc by calling the company number (919) 481-0990, as your correspondence is most welcome. Additionally, the physical location of the single location of Versagenics Inc can be found at the coordinates 35.82099,-78.80855 as well as the street address 14001 Weston Parkway # 101 in Cary, North Carolina 27513.
For its online presence, you may visit Versagenics Inc’s website at versagenics.com and engage with its social media outlets through on Twitter and on Facebook.